In a study of 677 patients with early breast cancer, it has been shown that patients with lost classical HLA-I and expressing HLA-E and HLA-G show a shorter relapse free period, compared to those expressing classical HLA-I [116]. This evidence concerns the gene HLA-G and breast cancer.